Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Mojtabai, R. Articles by Bromet, E. J. Search for Related Content PubMed Citation Articles by Mojtabai, R. Articles by Bromet, E. J. Hospitals, Hospital Treatment Schizophrenia Spectrum Disorders Conventional Neuroleptics

Gaps in Use of Antipsychotics After Discharge by First-Admission Patients With Schizophrenia, 1989 to 1996

The authors examined gaps in the use of antipsychotic medications during the one-year period after discharge in an epidemiological sample of 189 first-admission patients with schizophrenia between July 1989 and January 1996. Sixty-three percent of the patients had one or more such gaps, and 51 percent had gaps of 30 days or longer, with an average total time off medication of about seven months. Most gaps occurred soon after discharge, and 73 percent were initiated by the patient. These data, which were obtained before the widespread use of atypical antipsychotic agents, provide a benchmark against which to examine the impact of the newer medications on adherence and continuity of treatment in the critical early stages of schizophrenia.

This article has been cited by other articles:

				M. Linden, T. Scheel, and F.-X. Eich Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride J Psychopharmacol, November 1, 2006; 20(6): 815 - 823. [Abstract] [PDF]

				G. REMINGTON Rational pharmacotherapy in early psychosis The British Journal of Psychiatry, August 1, 2005; 187(48): s77 - s84. [Abstract] [Full Text] [PDF]

				P. J. Weiden, C. Kozma, A. Grogg, and J. Locklear Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia Psychiatr Serv, August 1, 2004; 55(8): 886 - 891. [Abstract] [Full Text] [PDF]

				R. C. Hermann and S. Provost Best Practices: Interpreting Measurement Data for Quality Improvement: Standards, Means, Norms, and Benchmarks Psychiatr Serv, May 1, 2003; 54(5): 655 - 657. [Full Text] [PDF]

				J. Menzin, L. Boulanger, M. Friedman, J. Mackell, and J. R. Lloyd Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program Psychiatr Serv, May 1, 2003; 54(5): 719 - 723. [Abstract] [Full Text] [PDF]

				P. Thieda, S. Beard, A. Richter, and J. Kane An Economic Review of Compliance With Medication Therapy in the Treatment of Schizophrenia Psychiatr Serv, April 1, 2003; 54(4): 508 - 516. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us